[1]
“63 Short term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion”, Nep J Oph, vol. 5, no. 1, pp. 63–68, Mar. 2013, doi: 10.3126/nepjoph.v5i1.7824.